Evidence map›Paper›PMID 41526363›Full record

ArticleNature communications2026

A general one-step protocol to generate impermeable fluorescent HaloTag substrates for in situ live cell application and super-resolution imaging.

Kilian Roßmann, Ulrich Pabst, Bianca C Baciu, Siqi Sun, Christiane Huhn, Christina Holmboe Olesen, Maria Kowald, Eleni Tapp, Marie Bieck, Ramona Birke and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Synthesis of Benzo[JACS Au · 2026
    Article
  4. Penta-ALFA-Tagged Substrates for Self-Labelling Tags Allow Signal Enhancement in Microscopy.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Kilian RoßmannLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0000-0003-4965-9669
Ulrich PabstLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0009-0007-0529-0720
Bianca C BaciuLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0009-0005-1053-3171
Siqi SunLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0009-0002-8291-3358
Christiane HuhnLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0000-0001-9862-8784
Christina Holmboe OlesenLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0000-0002-0575-1597
Maria KowaldLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0009-0001-4769-4834
Eleni TappLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0009-0005-6277-7813
Marie BieckLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Ramona BirkeLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Brenda C ShieldsDuke University, Departments of Neurosurgery, Neurobiology and Biomedical Engineering, Durham, NC, USA.ORCID http://orcid.org/0000-0001-9036-2686
Pyeonghwa JeongDuke University, Department of Chemistry, Durham, NC, USA.ORCID http://orcid.org/0009-0000-3796-7627
Jiyong HongDuke University, Department of Chemistry, Durham, NC, USA.ORCID http://orcid.org/0000-0002-5253-0949
Michael R TadrossDuke University, Departments of Neurosurgery, Neurobiology and Biomedical Engineering, Durham, NC, USA.ORCID http://orcid.org/0000-0002-7752-6380
Joshua LevitzWeill Cornell Medicine, Department of Biochemistry and Biophysics, New York, NY, USA.ORCID http://orcid.org/0000-0002-8169-6323
Martin LehmannLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0000-0002-8370-6353
Noa LipsteinLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0000-0002-0755-5899
Johannes BroichhagenLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany. broichhagen@fmp-berlin.de.ORCID http://orcid.org/0000-0003-3084-6595

Funding

DART2.0: comprehensive cell type-specific behavioral neuropharmacologyRF1MH117055 · NIMH · DUKE UNIVERSITY · PI TADROSS, MICHAEL R · 2018 to 2018
$3.8M
Mechanisms of Regulation of Metabotropic Glutamate ReceptorsR01NS129904 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Joshua Levitz · 2023 to 2026
$2.6M
Deutsche Forschungsgemeinschaft (German Research Foundation) CRC 1286 A11NIMH NIH HHS RF1 MH117055NINDS NIH HHS R01 NS129904
6 · The paper itself

Abstract

Visualization of proteins can be achieved by genetically grafting HaloTag Protein (HTP) into the protein of interest followed by incubation with a dye-linked HaloTag Ligand (HTL). This approach allows for use of fluorophores optimized for specific optical techniques or of cell-impermeable dyes to selectively label cell surface proteins. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Here we show that several dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed, using a one-step protocol. We validate such compounds, termed dye-SHTL (dye shuttle), in living cells, and demonstrate exclusive membrane staining. In transduced primary hippocampal neurons, we label a neuromodulatory receptor with dyes optimized for stimulated emission by depletion super-resolution microscopy, allowing accuracy in distinguishing surface versus internal receptors of the presynaptic terminal. This approach offers broad utility for surface-specific protein labelling.

Indexed as

Fluorescent DyesAnimalsHippocampusHumansLigandsMicroscopy, FluorescenceNeuronsRatsStaining and LabelingFluorescent DyesLigands

Identifiers

PMID41526363
PMCPMC12796469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.